online pharmacy:	minimal price:	best buy:	shipping:	payment method:	delivery to:
GenericMed	$63.31 - Pulmicort 100 mcg/inh 1 inhaler	$146.75 - Pulmicort 100 mcg/inh 3 inhalers	14/free		most countries
Tl-Pharmacy	- - -	- - -	10-21 days/free		every country
MedRx-One	- - -	- -	10 days/free		most countries
LeadMedic	$54.81 - 1 inhaler x 100 mcg/inh	$127.05 - 3 inhalers x 100 mcg/inh (+$72.24)	14-21days/$10 5-7 days/$25		every country
Pharma-Doc	- - -	- -	FedEx next day/$24		USA only
Med-Pen	- - -	- -	14-20 days/$10 7-14 days/$20		most countries
OurPharmacyRx	$49.20 - 1 inhaler x 100 mcg	$211.20 - 6 inhaler x 100 mcg	14-21 days/$15 5-12 days/$30		most countries
RxPharms	- - -	- - -	14-24 days/free		worldwide
RxMedShop	- - -	- - -	8-16 days/$20 5-9 days/$30 3-6 days/$40		most countries

Other names: Entocort, Pulmicort Inhaler, Rhinocort

CANDIDA ALBICANS: THE YEAST ALLERGY ? AN INCREASING PROBLEM
Until fairly recently Candida albicans was considered to be a harmless parasite which is carried by a significant percentage of the population. It is, in effect, a living yeast which consists of minute, single cell plants or fungi. Normally, this fungus lives harmlessly inside us, along with other microbes kept in check by the immune system. But if, for some reason, the immune system is not functioning properly, or if antibiotics destroy other microbes, the Candida albicans takes advantage of this situation and spreads. In a paper written by Dr Patricia Lucas of Germantown, Tennessee, entitled ‘Clinical Ecology Patients and Candida albicans’, she writes:
Candida albicans is a known pathogen capable of causing serious disease. Since World War Two, candidiasis has become one of the most common nosocomial, or hospital-acquired, infections. This increasing incidence is associated with the advent of antibiotics and other modern medical therapies, including immunosuppressive treatment of various diseases.
In other words, the widespread use of antibiotics and other drugs in many cases, is leading to a breakdown in the immune system. Once this happens, chronic illness sets in as the body becomes intolerant to one substance after another. Multiple food and chemical allergies develop and the individual becomes burdened by persistent, debilitating symptoms.
According to Dr Lucas, there are two main types of medically recognized candidal infection. Firstly, systemic candidiasis occurs when the yeast parasite gains entrance to the lymph system and the bloodstream, and circulates throughout the body causing infection (o one or several organs. Secondly, in chronic mucocutaneous candidiasis, the yeast infects the skin and mucous membranes of the body. As the former is extremely difficult to detect, and the latter considered rare, doctors normally do not give much thought to candidiasis as something which will bear fruitful investigation.
However, what Dr Lucas and her associates have discovered, in recent years, is that a large number of people do have a form of candidiasis. They took cultures from multiple allergy patients that showed in every case that these people were carriers of Candida albicans. They then proceeded to investigate, on the basis that these patients might suffer a type of candidiasis which did not fall into the two previously recognized groups. They found that in healthy people, colonisation of the mucosa in the intestine and other places was limited by a protective coating of mucous and secreted antibodies. These two mechanisms prevented the Candida yeast from getting in and doing harm.
In allergy sufferers however, their findings indicated that the protective mucous coating, particularly in the small intestine, was eroded at certain points, allowing the Candida to gain entrance to the body across a resultantly ‘leaky’ mucosa. This damage to the intestine could have been brought about by incorrect feeding during infancy. Once Candida gains access to the bloodstream, turmoil results as the immune system, swamped by the abnormally large numbers of Candida antigens, struggles to manufacture enough antibodies to destroy them. This situation is further aggravated by the apparent involvement of a Candida immunosuppressive mechanism that renders the immune system impotent to the yeast invasion. It is thought that the cause of such immunosuppression is the heavy circulating load of candidal antigens, combined with the body’s tendency to increased production of the immunosuppressive hormone, corticosterone. Thus other food and chemical substances which gain access to the bloodstream, are free to provoke allergic reactions, unhindered by the immune system.
This means that a previously undetected yeast intolerance, in the form of inapparent candidiasis, can be responsible for chronic multiple allergy illness. The good news for allergy sufferers is that this disease can be effectively treated, once diagnosed. Laboratory tests, called ELISA (Enzyme-Linked Immunosorbent Assays), have been developed in the United States to enable a more accurate diagnosis of candidiasis.
Dr C. Orian Truss of Birmingham, Alabama, is one of a number of eminent internists and allergists in the United States who has studied the Candida problem, both clinically and scientifically. In his excellent paper titled ‘Restoration of Immunologic Competence to Candida albicans’, published in the Journal of Orthomolecular Psychiatry, he refers to the ‘paralysing’ effect of Candida on the immune system which causes ‘toxic responses to soluble yeast products’. He says that the cause of the paralysis is an overloading of yeast toxins in the system. Once this overload is reduced back to a manageable level, the immune system regains its function and can effectively deal with the problem. Of the greatest importance to many patients with chronic candidiasis is the development of intolerance to foods, drugs and chemicals. A careful history often reveals the earliest of these intolerances occurring in the first several years after the symptoms of chronic yeast infection. Thereafter occurs a rapidly accelerating inability to tolerate environmental chemicals, whether they be as ‘foods’, ‘drugs’ or ‘chemicals’. Eventually these patients may literally become unable to live in normal environments resorting for relief to the most dramatic measures of environmental control. They are unable to work and may even move to remote areas in their attempt to minimise the total load of chemicals contacted in their daily lives.
The doyen of American Allergists, Dr Theron Randolph, has since 1962, published several medical papers and articles on the connection between yeast infection and multiple masked allergy illness. According to Dr Randolph, the problem began in the 1950s, which coincides with the commencement of widespread, and often irresponsible, prescription by doctors of antibiotics, particularly broad spectrum antibiotics, which are harmful to the immune system. Dr Truss makes the point that all drugs are potentially lethal lo the immune system. Prolonged exposure enables Candida to become systemic, resulting in further intolerances to drugs, foods and chemicals.
It is important to remember that each of us is different and can be affected to varying degrees. Many people have candidiasis-linked allergy problems and, as a result, may have suffered a lifetime of ill health without the cause ever becoming known.
*21/106/2*

Responses are currently closed, but you can trackback from your own site.